Australian Paediatric Surveillance Unit Annual Report 2018
DOI:
https://doi.org/10.33321/cdi.2019.43.53Keywords:
children, communicable disease, emerging infectious diseases, public health surveillance, rare disease, Australia, Zika virusAbstract
The Australian Paediatric Surveillance Unit (APSU) has been conducting active, prospective, national surveillance for rare diseases of children over the last 25 years with monthly reporting by paediatricians. Communicable diseases currently under surveillance include: acute flaccid paralysis (to identify potential cases of poliovirus infection); congenital cytomegalovirus infection; neonatal herpes simplex virus infection; perinatal exposure to human immunodeficiency virus (HIV) and paediatric HIV infection; juvenile onset recurrent respiratory papillomatosis; severe complications of influenza (undertaken during the influenza season June to September 2018); congenital rubella infection; and severe complications of varicella virus infection including neonatal and congenital varicella infection. Of related interest is the study of microcephaly in infants less than 12 months of age, for which monitoring commenced in relation to the emergence of Zika virus and finished at the end of July 2018.
Downloads
References
Elliott EJ, Chant KG. Rare disease surveillance. J Paediatr Child Health. 1994;30(6):463–5.
Webb P, Bain C, Page A. Essential epidemiology: an introduction for students and health professionals. United Kingdom, Cambridge University Press, 2016.
Zurynski YA, Lester-Smith D, Festa MS, Kesson AM, Booy R, Elliott EJ. Enhanced surveillance for serious complications of influenza in children: role of the Australian Paediatric Surveillance Unit. Commun Dis Intell Q Rep. 2008;32(1):71–6.
Zurynski Y, Elliott EJ. Australian Paediatric Surveillance Unit annual report, 2010. Commun Dis Intell Q Rep. 2011;35(3):244–9.
Teutsch S, Zurynski Y, Elliott E. Australian Paediatric Surveillance Unit Annual Report, 2017. Commun Dis Intell (2018). 2018;42. pii: S2209-6051(18)00006-4.
Deverell M, Phu A, Zurynski Y, Elliott E. Australian Paediatric Surveillance Unit Annual Report, 2016. Commun Dis Intell Q Rep. 2017;41(3):E288–93.
Roberts J, Hobday L, Ibrahim A, Aitken T, Thorley B. Annual report of the Australian National Enterovirus Reference Laboratory 2012. Commun Dis Intell Q Rep. 2013;37(2):E97–104.
Rawlinson WD, Palasanthiran P, Hall B, Al Yazidi L, Cannon MJ, Cottier C et al. Neonates with congenital cytomegalovirus and hearing loss identified via the universal newborn hearing screening program. J Clin Virol. 2018;102:110–5.
Zheng QY, Huynh KT, van Zuylen WJ, Craig ME, Rawlinson WD. Cytomegalovirus infection in day care centres: A systematic review and meta‐analysis of prevalence of infection in children. Rev Med Virol. 2019;29(1):e2011.
Shand A, Luk W, Nassar N, Hui L, Dyer K, Rawlinson W. Cytomegalovirus (CMV) infection and pregnancy-potential for improvements in Australasian maternity health providers’ knowledge. J Matern Fetal Neonatal Med. 2018;31(19):2515–20.
Lazzaro A, Vo M, Zeltzer J, Rawlinson W, Nassar N, Daly K et al. Knowledge of congenital cytomegalovirus (CMV) in pregnant women in New South Wales (NSW) is low and improved with education. Aust N Z J Obstet Gynaecol. 2019. https://doi.org/10.1111/ajo.12978.
Rawlinson WD, Boppana SB, Fowler KB, Kimberlin DW, Lazzarotto T, Alain S et al. Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy. Lancet Infect Dis. 2017;17(6):e177–88.
Kirby Institute. HIV, viral hepatitis and sexually transmissible infections in Australia: annual surveillance report 2018. Sydney: Kirby Institute, UNSW Sydney. 2018.
Novakovic D, Cheng ATL, Zurynski Y, Elliott E, Booy R, Walker PJ et al. A prospective study of the incidence of juvenile-onset recurrent respiratory papillomatosis after implementation of a national HPV vaccination program. J Infect Dis. 2018;217(2):208–12.
Blyth CC, Macartney KK, McRae J, Clark JE, Marshall HS, Buttery J et al. Influenza epidemiology, vaccine coverage and vaccine effectiveness in children admitted to sentinel Australian hospitals in 2017: results from the PAEDS-FluCAN collaboration. Clin Infect Dis. 2019;68(6):940–8.
National Notifiable Diseases Surveillance System (NNDSS). Number of notifications of Rubella congenital, Australia, in the period of 1991 to 2018 and year-to-date notifications for 2019. [Internet.] Australian Government, Department of Health, 2019. Available from: http://www9.health.gov.au/cda/source/rpt_3.cfm.
Sathanandan D, Gupta L, Liu B, Rutherford A, Lane J. Factors associated with low immunity to rubella infection on antenatal screening. Aust N Z J Obstet Gynaecol. 2005;45(5):435–8.
Cragan JD, Isenburg JL, Parker SE, Alverson CJ, Meyer RE, Stallings EB et al. Population-based microcephaly surveillance in the United States, 2009 to 2013: An analysis of potential sources of variation. Birth Defects Res Part A Clin Mol Teratol. 2016;106(11):972–82.
Zurynski Y, Gonzalez A, Deverell M, Phu A, Leonard H, Christodoulou J et al. Rare disease: a national survey of paediatricians’ experiences and needs. BMJ Paediatr Open. 2017;1(1):e000172.
Elliott E, Zurynski Y. Rare diseases are a ‘common’ problem for clinicians. Aust Fam Physician. 2015;44(9):630–3.
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2019 Communicable Diseases Intelligence
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
